2771 results found
The National Health and Medical Research Council (NHMRC) is updating the Guidelines for Managing Risks in Recreational Water (the Guidelines).
The NHMRC Corporate Plan 2023–24 presents our strategy for building a healthy Australia, across the strategic themes (purposes) of investment, translation and integrity of health and medical research. The plan also includes our strategic and health priorities, as well as our key activities planned for 2023–24 and over the next four years. The plan describes the operating context in which we work and outlines our performance criteria and targets for the next 4 years. The key elements of our Corporate Plan 2023–24 are summarised in the Plan on a Page.
Our Open Access Policy (the Policy) is underpinned by the principle that publicly-funded research should be shared openly and at the earliest possible opportunity. Open access is about making research outputs freely available to use and share, which is distinct from simply 'free to read'.
The daily burden of living with diabetes can be significant. It’s estimated that people with diabetes face up to 180 diabetes-related decisions every day. That’s more than 65,000 extra decisions a year. These decisions can range from managing daily blood sugar levels, food intake and exercise to the management of serious diabetes complications.
The NHMRC Corporate Plan 2021–22 presents our national strategy for health and medical research aligned with our three strategic purposes of investment, translation and integrity. The plan includes updated strategic priorities and health priorities and outlines our planned key activities in 2021–22 and over the next four years. The plan also describes the operating context in which we work and our performance criteria and targets for the next four years.
The National Health and Medical Research Council (NHMRC) Corporate Plan 2022–23 presents our national strategy for health and medical research aligned with our three strategic purposes of investment, translation and integrity. The plan also includes our strategic priorities and health priorities and outlines our key activities planned for 2022–23 and over the next four years. In addition, the plan describes the operating context in which we work and our performance criteria and targets for the next four years
Emily McDonald’s journey to becoming an intern at NHMRC has not been exactly straightforward.
As one of NHMRC’s first Indigenous Interns, Nada Powell is about to embark on her next journey which is likely to now include research.
Sharna Motlap has always been interested in creating and implementing evidence-based programs specifically tailored to Indigenous communities.
Deciding to commit to a research life is brave – so is committing to do the hard research. Professor Cath Chamberlain says with Aboriginal and Torres Strait Islander health, in particular, 'we are going to need to take some more risks to do things differently'.
Surprisingly, understanding of organ assembly is extremely limited. Professor Melissa Little and team received an Human Frontier Science Program (HFSP) grant and established the most comprehensive quantitative image-based analysis of any organ ever described. The challenges of bringing together researchers from different fields is one of vocabulary, but the benefit is considerable.
Lipid droplets are exploited by pathogens that invade cells and then use the cellular lipid droplets as a source of fats. Professor Rob Parton and his team received a Human Frontier Science Program (HFSP) grant to explore the possibility that lipid droplets might also be a crucial form of defence against pathogens. International collaborative networks have allowed access to techniques and expertise. They have also facilitated mentoring and collaboration for students and early career researchers.
Around 1,786 new cases of ovarian cancer in Australia were estimated to have been diagnosed in 2023, which is the equivalent of a 1 in 87 lifetime risk.In our first Speaking of Science webinar, held for Ovarian Cancer Awareness Month, we were joined by international expert in ovarian cancer research, Professor Susan Ramus (Professor of Molecular Oncology in the School of Clinical Medicine at the University of New South Wales).
The National Health and Medical Research Council (NHMRC) has established the Iodine Expert Working Group to support the review and update of the iodine Nutrient Reference Values for Australia and New Zealand (NRVs).
It is a requirement that all Institutional approvals be obtained and lodged with the MRFF EOs Research Administration Officer (RAO) by the time it is necessary to perform the relevant part(s) of the research activity and all institutional approvals are to be maintained as required for the duration of the grant.